| Original language | English (US) |
|---|---|
| Pages (from-to) | 1470-1472 |
| Number of pages | 3 |
| Journal | JACC: Cardiovascular Imaging |
| Volume | 14 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2021 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JACC: Cardiovascular Imaging, Vol. 14, No. 7, 07.2021, p. 1470-1472.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Coronary Artery Calcium for the Allocation of GLP-1RA for Primary Prevention of Atherosclerotic Cardiovascular Disease
AU - Cainzos-Achirica, Miguel
AU - Patel, Kershaw V.
AU - Quispe, Renato
AU - Joshi, Parag H.
AU - Khera, Amit
AU - Ayers, Colby
AU - Lima, Joao A.C.
AU - Rana, Jamal S.
AU - Greenland, Philip
AU - Bittencourt, Marcio S.
AU - Cardoso, Rhanderson
AU - Blankstein, Ron
AU - Blumenthal, Roger S.
AU - Blaha, Michael J.
AU - Nasir, Khurram
N1 - Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Todd Villines, MD, served as the Guest Editor of this paper. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org . Funding Information: MESA: This research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201500003I and N01-HC-95159 through N01-HC-95169, and by National Center for Advancing Translational Sciences grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, and UL1-TR-001881. CARDIA was supported by NHLBI contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I. Dallas Heart Study: This work is supported in part by the National Center for Advancing Translational Science, National Institutes of Health grant UL1TR001105. Dr. Joshi has received grant funding from Novo Nordisk. Dr. Blaha has served on the advisory board of Novo Nordisk. Dr. Nasir has served on advisory boards for Amgen, Novartis, and The Medicine Company; and his research is partly supported by the Jerold B. Katz Academy of Translational Research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors thank the other investigators, staff, and participants of the MESA, CARDIA, and Dallas Heart Study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
PY - 2021/7
Y1 - 2021/7
UR - http://www.scopus.com/inward/record.url?scp=85101693762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101693762&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2020.12.024
DO - 10.1016/j.jcmg.2020.12.024
M3 - Letter
C2 - 33582063
AN - SCOPUS:85101693762
SN - 1936-878X
VL - 14
SP - 1470
EP - 1472
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 7
ER -